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Abstract The current study was to investigate the interac-
tion between Helicobacter pylori and human dendritic cells
(DCs). Whether impaired DC function can influence the
outcome of H. pylori infections. Human monocyte-derived
DCs (MDDCs) from five gastric cancer patients and nine
healthy controls were stimulated with H. pylori. Maturation
markers of MDDC were examined by flow cytometry. IL-10
and TNF-α released by MDDCs and IL-17 produced by T
cells were measured by ELISA. Regulatory signaling path-
ways of IL-10 were examined by ELISA, western blotting,
and chromatin immunoprecipitation assay. The results showed
that as compared with healthy individuals, the maturation
marker CD40 in MDDCs, IL-17A expression from T cells,
and IL-10 expression from MDDCs were significantly lower
in gastric cancer patients. Blocking DC-SIGN, TLR2, and
TLR4 could reverse H. pylori-associated IL-10 production.
Activation of the p38 MAPK and NF-kB signaling pathways
concomitant with decreased tri-methylated H3K9 and in-
creased acetylated H3 accounted for the effect of H. pylori
on IL-10 expression. Furthermore, upregulated IL-10 expres-
sion was significantly suppressed inH. pylori-pulsed MDDCs
by histone acetyltransferase and methyltransferase inhibitors.
Taken together, impaired DC function contributes to the less
effective innate and adaptive immune responses against H.
pylori seen in gastric cancer patients. H. pylori can regulate
IL-10 production through Toll-like and DC-SIGN receptors,
activates p-p38 MAPK signaling and the transcription factors
NF-kB, and modulates histone modification.
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Introduction
Helicobacter pylori is a Gram-negative, spiral-shaped bacte-
rium that can colonize the human gastric mucosa. H. pylori
infections are highly prevalent and a wide range of clinical
manifestations have been observed. Most people infected with
H. pylori have asymptomatic gastritis, but approximately 10%
of infected patients develop gastric or duodenal ulcers, and
1% develop gastric adenocarcinoma (Fock and Ang 2010).
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These diverse outcomes have been attributed to the interplay
of several factors, including H. pylori virulence, host genetic
susceptibility and local immune responses, and environmental
conditions. The VacA (vacuolating cytotoxin A) and the Cag
(cytotoxin-associated gene) pathogenicity island of H. pylori
have been shown to cause adverse outcomes, but these factors
are not predictive of the development of gastric cancer in H.
pylori-infected patients (Backert and Selbach 2008).
The host immune response to the bacterium is an intrinsic
component in the pathogenesis of these diseases, and growing
evidence indicates that dendritic cells (DCs) are involved in the
response toH. pylori infection (Andres et al. 2011; Bimczok et
al. 2010; Necchi et al. 2009). DCs are professional antigen-
presenting cells with critical roles in the initiation and progres-
sion of innate and adaptive immunity (Banchereau et al. 2000).
Mouse studies have shown that DCs are recruited to the gastric
mucosa afterH. pylori infection (Kao et al. 2006, 2010). Using
two photon and confocal microscopy, Rescigno et al. localized
DCs to close to the surface epithelium of the normal intestine
and also showed that their cellular processes extend into the
epithelial layer (Rescigno et al. 2001).
DCs are also known to traverse the gut epithelium tight
junction to sample luminal bacteria (Ito et al. 2008) and deliver
them to nearby lymph nodes, where they then activate naïve T
cells and direct the T-cell response, according to their state of
activation (Ismail et al. 2003; Lundgren et al. 2005; Sansonetti
and Di Santo 2007). These data suggest that DCs are a front
line of host immune responses toH. pylori infection and play a
central role in determining whether an infected host clears the
bacteria or goes on to develop chronic inflammation.
Although the precise mechanisms by which H. pylori
induces carcinogenesis are still unclear, inflammation is the
most commonly cited factor in the carcinogenic process.
Various cytokines produced by DCs are known to affect the
outcome of subsequent T-cell activation: TNF-α, IFN-γ, and
IL-12 drive Th1 responses while IL-4, IL-10, and IL-13
promote Th2/Treg responses (Moser and Murphy 2000).
The accumulation ofH. pylori-specific CD4+ Tcells observed
in infected human gastric mucosa suggests that CD4+ T-cell-
mediated Th1 immune responses may be critical in the devel-
opment of H. pylori-induced gastritis (Bimczok et al. 2010).
The cytokine IL-10, which has potent anti-inflammatory and
immune regulatory properties, inhibits various inflammatory
cytokines, including IL-12, and may down-regulate host Th1-
type responses to gastric H. pylori infection. IL-10 knockout
mice infected with Helicobacter felis demonstrate that a lack
of IL-10 causes severe chronic gastritis and substantially
enhances the Helicobacter-specific Th1 immune response
(Ismail et al. 2003). Although the role of TLRs (Toll-like
receptors) in the macrophage response to H. pylori infection
has been studied intensively, only a few reports concerning
the role of TLRs and DC-SIGN (Dendritic Cell-Specific In-
tercellular adhesion molecule 3-Grabbing Non-integrin)
receptors in DCs during H. pylori infections (Bergman et al.
2004; Gringhuis et al. 2009).
This study investigated the effects of H. pylori on DC
activation and maturation and the functional consequences
of these effects on naïve T cells. We also examined the
regulatory signal pathways in IL-10 cytokine production after
H. pylori stimulation and compared the cytokine profiles of
healthy individuals and gastric cancer patients after stimula-
tion with H. pylori. Histone remodeling by bacterial and viral
pathogens has recently been shown to influence immune
responses during infection (Li et al. 2007), and we therefore
also analyzed epigenetic effects during H. pylori infections.
Materials and methods
Bacteria and growth conditions
H. pylori strain ATCC 26695 was inoculated on CDC culture
medium (BBL Microbiology System, Cockeysville, MD,
USA) for 3 days under micro-aerophilic conditions (12%
CO2 and 5% O2) at 37 °C. H. pylori was identified by colony
morphology and through positive biochemical tests for
ureases, catalase, and oxidase. The characteristic curvy shape
of H. pylori was also observed under microscope by Gram
staining. For further experiments, H. pylori was prepared in
0.9% saline solution at a concentration of 1×109 bacteria/ml,
which was measured by optical density determination at
550 nm and adjusted to a final absorbance of 0.75.
Monocyte-derived dendritic cell (MDDC) isolation, culture,
and treatment with H. pylori
The study of human subjects was approved by the Institutional
ReviewBoard of KaohsiungMedical University, Taiwan. After
obtaining informed consent, 150–200ml peripheral blood were
obtained and peripheral blood mononuclear cells (PBMCs)
were isolated with Ficoll-Paque (Pharmacia Biotech, Uppsala,
Sweden) from healthy individuals with no history of H. pylori
infection (n09) and from gastric cancer patients (n05). Blood
monocytes were magnetically sorted with CD14 isolation kits
(Miltenyi Biotec, Gmbh Bergisch Gladbach, Germany), fol-
lowing the manufacturer’s instructions. MDDCs were obtained
by culturing purified monocytes in RPMI 1640 medium con-
taining 10% FCS, 100 IU/ml penicillin, 0.1 mg/ml streptomy-
cin, 50 ng/ml granulocyte–macrophage colony-stimulating
factor (GM-CSF; BD Pharmingen, San Diego, CA, USA),
and 10 ng/ml IL-4 at 37 °C for 7 days. Purified MDDCs (2×
105 cells) from healthy individuals and patients were treated
with various doses of H. pylori (multiplicity of infection,
MOI01:100 or 1:200) and incubated for 6, 24, or 48 h, depend-
ing on the experiment. To examine the involvement of the
DC-SIGN and TLRs, MDDCs were pre-treated with anti-DC-
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SIGN, TLR2, or TLR4 antibodies (BD Biosciences, San Jose,
CA, USA) 1 h prior to treatment with H. pylori. To determine
the roles of the three MAPK (mitogen-activated protein
kinases) signaling transduction pathways in IL-10 expression,
MDDCs were pre-treated with inhibitors of ERK (extracellular
signal-regulated kinases, PD98059), p38MAPK (SB203580),
JNK (Jun N-terminal kinase, SP600125), and IκB-alpha phos-
phorylation (BAY-117082) 1 h before exposure to H. pylori.
All MAPK and IκB-alpha inhibitors were purchased from
Sigma-Aldrich (St. Louis, MO, USA). To evaluate histone
modification involving IL-10 expression,MDDCswere treated
with histone acetyltransferase inhibitor anacardic acid (AA,
0.2 μg/ml) and histone methyltransferase inhibitor 5′-deoxy-
5′-(methylthio) adenosine (MTA, 0.1μg/ml) (BDPharmingen).
The production of cytokines in the culture supernatants was
determined by enzyme-linked immunosorbent assay (ELISA).
Western blotting
For Western blotting analysis, MDDCs were treated with H.
pylori (multiplicity of infection, MOI01:100 or 1:200) for
1 h and then lysed. Equal quantities of whole cell lysates
were analyzed by Western blotting with anti-p65, anti-
phospho-p65 (pp65), anti-p38, anti-phospho-p38, anti-
ERK, anti-phospho-ERK, anti-JNK, and anti-phospho-JNK
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA,
USA). Immunoreactive bands were visualized using horse-
radish peroxidase-conjugated secondary antibodies and the
enhanced chemiluminescence (ECL) system (Amersham
Pharmacia Biotech, Uppsala, Sweden).
Naïve T-cell purification and co-culture with H. pylori-treated
MDDCs
Autologous naïve CD4+ T cells were purified from PBMCs
by using CD4 magnetic beads (Miltenyi Biotec GmbH,
Germany) and activated with CD3 and CD28 antibodies
(eBioscience, San Diego, CA, USA). After treatment with
H. pylori for 48 h, MDDCs were co-cultured with autolo-
gous naïve T cells (DC/T cell ratio 1:10, the optimal ratio for
cytokine assay) for 7 days. Cell culture supernatants were
collected for IL-17A measurement by ELISA assay.
ELISA for determination of cytokine levels
The presence of IL-10, TNF-α, and IL-17A in culture super-
natants was determined by ELISA (R&D Systems, Minne-
apolis, MN, USA).
MDDC activation and maturation
MDDCs (5×105 cells) were incubated in the presence of
108 CFUH. pylori for 48 h in RPMI 1640 medium
supplemented with 10% FCS. MDDCs were then stained with
the following mAbs to evaluate the maturation by flow cytom-
etry: FITC conjugated anti-HLA-DR, FITC conjugated anti-
CD80, FITC conjugated anti-CD40, or FITC conjugated anti-
CD86 (all mAbs from BD Biosciences, MA, USA). Surface
markers of DCs were analyzed using a FACScan flow cytom-
eter and CellQuest software (Becton Dickinson).
Chromatin immunoprecipitation assay (ChIP)
Changes in histone modification were quantitatively ana-
lyzed by ChIP along the promoter region of the IL-10 genes
after stimulation with H. pylori. The ChIP assays were
performed according to the manufacturer’s protocol with
minor modifications. MDDCs (5×105 cells) were treated
with 1% formaldehyde for 10 min at RT followed by
DNA sonication to 200 to 400 bp. Chromatin was immuno-
precipitated overnight with antibodies for acetylated histone
H3 and H4 and for tri-methylated H3K4, H3K9, H3k36, and
H3k79 (Upstate Biotechnology, Waltham, MA, USA). Im-
mune complexes were collected using a protein A slurry
(Invitrogen, Carlsbad, CA, USA), and the DNAwas reverse
cross-linked, extracted, and quantified with SYBR Green-
based detection (Applied Biosystems, Foster City, CA,
USA) on a TaqMan SDS 7900HT.
The primers used to amplify specific regions of the IL-10
promoter were as follows: IL-10-1, 5′-TATTCTAAGAGAG
GTAGCCCATCCT-3′ and 5′-CTTCATTCATTAAAAAGC
CACAATC-3 ′; IL-10-2, 5 ′-CCGCCTGTACTGTAG
GAAGC-3′ and 5′-CCCCAACCTGGGATGAATAC-3′; and
GAPDH, 5 ′ -CGGTGCGTGCCCAGTT-3 ′ and 5 ′ -
CCCTACTTTCTCCCCGCTTT-3′. The PCRs were run on
an ABI TaqMan SDS 7900HT thermocycler. All TaqMan
reagents were purchased from Applied Biosystems. The rela-
tive intensities of the amplified products were normalized to
the input DNAs and plotted graphically as fold changes.
Statistical analysis
All data were analyzed by Mann–Whitney tests except for
the ChIP assay in which ANOVA tests were used. Data are
presented as means±SE. A p value ≤0.05 was considered as
a significant difference.
Results
A reduced expression of CD40 in H. pylori-primed MDDCs
from gastric cancer patients
To examine the effects of H. pylori on DC maturation,
expression of co-stimulator and antigen-presenting mole-
cules (CD80, CD40, CD86, and HLA-DR) in MDDCs was
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evaluated by flow cytometry after H. pylori stimulation for
48 h. Figure 1 shows that immature MDDCs from gastric
cancer patients and healthy individuals significantly in-
creased the surface expression of CD40, CD80, CD86, and
HLA-DR following stimulation with H. pylori. However,
the expression of CD40 co-stimulatory molecules was sig-
nificantly lower in DCs from gastric cancer patients than in
those from healthy individuals, both with and without H.
pylori stimulation (Fig. 1a).
Weakened Th17 responses are induced by H. pylori-treated
MDDCs from gastric cancer patients
Since binding of CD154 (CD40L) on T helper cells to CD40
on MDDC may further activate MDDC and induce a variety
of downstream effects, our data suggested that a reduced
capacity of MDDC primed by H. pylori to express CD40
may weaken the function of MDDC and the communication




























































Fig. 1 Expression of surface markers on H. pylori-primed MDDCs
from gastric cancer patients and healthy individuals. Mean fluores-
cence intensity (MFI) expression of co-stimulatory molecules a CD40,
b HLA-DR, c CD80, and d CD86 in MDDCs was detected by flow
cytometry. CD40 expression was significantly lower in MDDCs from
gastric cancer patients. One of three representative experiments is
shown. Isotype control: black, normal control: light gray, patient
control: heavy gray, normal H. pylori 1:200: black plot line, patient
H. pylori 1:200: black heavy line. *p00.05; NS non significant
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To characterize the Th response induced by MDDCs
pulsed with H. pylori, CD4+ T cells purified from PBMCs
were co-cultured with H. pylori-treated MDDCs for 7 days.
Supernatant was collected for IL-17A measurement by
ELISA. The IL-17A level in MDDCs of healthy individuals
and gastric cancer patients challenged with H. pylori was
significantly higher than in MDDCs which were not pulsed
withH. pylori. However, IL-17A production was significantly
lower in MDDCs from gastric cancer patients than from
healthy individuals (Fig. 2). We therefore conclude that im-
mature MDDCs pulsed with H. pylori do not induce a robust
Th17 response in gastric cancer patients. Since IL-17 is pri-
marily associated with gastric inflammation and targets extra-
cellular pathogens, weakened Th17 response induced by
MDDC from gastric cancer patients may contribute to an
impaired immunity against extracellular pathogens, thereby
favoring bacterial persistence in cancer patients.
Impaired production of IL-10, but not TNF-α,
from MDDCs from gastric cancer patients
Stimulation with H. pylori induced IL-10 and TNF-α pro-
duction by MDDCs of healthy individuals in a dose-
dependent manner (Fig. 3a, b). Kinetic analysis of cytokine
production by MDDCs stimulated with H. pylori showed
that IL-10 and TNF-α production significantly increased
after 6 h and reached saturation levels after 48 and 24 h,
respectively (Fig. 3a, b). Analysis of IL-10 production indi-
cated that stimulation with a MOI of 200 (multiplicity of
infection of MDDCs—H. pylori01:200) resulted in maxi-
mum cytokine release. Therefore, at 48 h, 200-MOI dose
was considered optimal for stimulating IL-10 in subsequent
experiments. To compare whether the responses of MDDCs
in the presence of H. pylori differ between gastric cancer
patients and healthy individuals, IL-10 and TNF-α produc-
tion of MDDCs from gastric cancer patients were also
analyzed. Interestingly, MDDCs from gastric cancer patients
revealed no significant IL-10 production after H. pylori
stimulation. Furthermore, IL-10 expression was significantly
lower inMDDCs from gastric cancer patients than inMDDCs
from healthy individuals (Fig. 3c). However, TNF-α expres-
sion did not significantly differ between gastric cancer patients
and healthy individuals after H. pylori exposure (Fig. 3d).
H. pylori induces IL-10 production via DC-SIGN, TLR2,
and TLR4 receptors in MDDCs
The mechanisms by which IL-10 production is regulated
following H. pylori infection are not clearly understood. We
found that H. pylori-induced IL-10 production in MDDCs
was significantly suppressed by the addition of anti-DC-
SIGN, TLR2, or TLR4 antibodies either alone or in combi-
nation before H. pylori stimulation (Fig. 4). Notably, these
receptor antagonists resulted in similar suppressive effects
on IL-10 expression in MDDCs (Fig. 4).
Production of IL-10 in MDDCs is induced by H. pylori via
p38 MAPK signaling and NF-kB activation
MAPK and NF-kB are important intermediates in TLR-
mediated signaling pathways. A p38-MAPK inhibitor
(SB203580) and an NF-kB p65 inhibitor (BAY-117082)
suppressed H. pylori-induced IL-10 expression whereas nei-
ther an ERK inhibitor (PD98059) nor a JNK inhibitor
(SP600125) had inhibitory effects (Fig. 5a). These data
suggest that p38/MAPK and NF-kB activation are critical
for sustaining H. pylori-mediated IL-10 production. Western
blot analysis further confirmed that the increased phosphor-
ylation of p38 and p65 in response to H. pylori stimulation
activated the MAPK and NF-kB signaling pathways in H.
pylori-treated MDDCs (Fig. 5b). Notably, H. pylori induced
IL-10 production through activation of the p38 MAPK and
p65 NF-kB pathways but not through activation of the ERK
and JNK pathways.
H. pylori regulates IL-10 production through histone
modifications
Histone modification has been implicated as an important
process for controlling gene expression (Li et al. 2007). To
determine the effect of histone modification on IL-10 gene
transcription, ChIP assays were performed. Histone H3 and
H4 acetylation as well as H3K4, H3K9, H3K36, and H3K79
trimethylation were tested for regulating effects on IL-10 gene
expression. The IL-10 promoter locus of H. pylori-treated
MDDCs exhibited increased acetylation of H3 (Fig. 6a) and
decreased trimethlyation of H3K9 (Fig. 6d). Histone acetyla-
tion has been reported to be associated with increase of gene
transcription, while H3K9 trimethylation is related to the in-
crease or decrease of gene transcription (Li et al. 2007). Our
















Fig. 2 IL-17A expression induced by H. pylori-treated MDDCs dif-
fers between gastric cancer patients and healthy individuals. Induction
of IL-17A production after co-culture of naïve T cell with H. pylori
pulsed MDDCs from healthy individuals or gastric cancer patients. IL-
17A expression differs between these two groups, as measured by
ELISA. Data are presented as means and standard deviation of three
independent experiments. Mann–Whitney tests were used to calculate
statistical significance. *p <0.05; **p <0.01
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withH. pylori is a prerequisite for IL-10 gene transcription. The
involvement of histone acetylation and methylation in IL-10
expression was further supported by observations of MDDCs
stimulated with H. pylori after 1-h treatment with histone
acetyltransferases inhibitor AA and histone methyltransferase
inhibitor MTA. Forty-eight hours after stimulation, the cell
supernatants were harvested and tested for IL-10 production
by ELISA. IL-10 production was significantly decreased in
MDDCs treated with AA and MTA (Fig. 6g). These
observations confirm the important role ofH. pylori in control-
ling histone epigenetic modification to regulate IL-10
expression.
Discussion
Recent studies indicate that the host immune response is










































































cMDDC cMDDC+Hp (1:200)cMDDC+Hp (1:100) cMDDC cMDDC+Hp (1:200)cMDDC+Hp (1:100)
MDDC MDDC+Hp (1:200)MDDC+Hp (1:100) MDDC MDDC+Hp (1:200)MDDC+Hp (1:100)
Fig. 3 Production of IL-10 and TNF-α from MDDCs after H. pylori
stimulation. H. pylori induces IL-10 (a) and TNF-α (b) production by
MDDCs from healthy individuals in a dose- and time-dependent man-
ner (n09 individuals). c MDDCs from five gastric cancer patients did
not produce significant levels of IL-10 after H. pylori stimulation, and
IL-10 production was significantly lower than in MDDCs from healthy
individuals. d TNF-α expression did not differ between gastric cancer
patients and healthy individuals after H. pylori exposure. **p <0.01,
*p <0.05 was considered significant versus untreated cells, NS non-













MDDC + + + + + + + + +
H. p  - + + + + + + + +
ADS - - + - - - + + +
anti-TLR2 - - - + - + + + -
anti-TLR4 - - - - + + + - +
** ** ** ** ** ** **
Fig. 4 H. pylori induced IL-10 production via DC-SIGN, TLR2, and
TLR4 receptors in MDDCs. IL-10 expression in H. pylori-infected
MDDCs from nine healthy individuals in the absence or presence of
anti-DC-SIGN, TLR2, or TLR4 antibody, either alone or in the indi-
cated combination for 1 h prior to the treatment of MDDCs with H.
pylori, was evaluated by ELISA. Statistical significance was deter-
mined with one-way ANOVA test. **p <0.01 was considered signifi-
cant compared with cells not treated with antibody. TLR2 toll-like
receptor 2, TLR4 toll-like receptor 4
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al. 2010; Suerbaum and Michetti 2002). Previous studies of
the host response to H. pylori have focused on the role of
macrophages (Keep et al. 2010), but the presence of DCs in
the surface epithelium of the gastric mucosa and their re-
cruitment during H. pylori infection suggest that DCs are
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a bFig. 5 H. pylori increasesIL-10 production in MDDCs
via the p38 MAPK and p65 NF-
kB pathways. a The level of IL-
10 expression in H. pylori-
infected MDDCs in the pres-
ence of 2 μM I-kB inhibitor
BAY-117082, p38 phosphory-
lation inhibitor SB203580, JNK
phosphorylation inhibitor
SP600125, and ERK phosphor-
ylation inhibitor PD98059. b
Western blot analyses of phos-
phorylated p65, p38, ERK, JNK
(pp65, pp38, pERK, pJNK),
and total p65, p38, ERK, JNK,
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Fig. 6 H. pylori regulates IL-10 production via histone modifications
in healthy controls. A ChIP assay was used to analyze the relative
levels of a acetylated H3 and b acetylated H4, c tri-methylated H3K4,
d H3K9, e H3K36, and f H3K79 at the IL-10 gene promoter region of
nine healthy individuals. g IL-10 production was significantly lower in
MDDCs treated with the histone acetyltransferase inhibitor anacardic
acid (AA) and the histone methyltransferase inhibitor MTA. *p <0.05,
**p <0.01, ***p <0.001
Appl Microbiol Biotechnol (2012) 96:211–220 217
Fully mature DCs upregulate co-stimulatory and adhesion
molecules (e.g., CD40, CD54, CD80, and CD86) and MHC
class II antigens, but decrease antigen uptake and processing
(Langenkamp et al. 2000; Moser and Murphy 2000), which
plays a key role in regulating innate and adaptive immunity. In
contrast, immature DCs do not form stable DC–effector T cell
contacts and prevent the effective priming of an immune
response. Therefore, the presence of immature DCs may
facilitate the persistence of pathogens and their ability to
evade or subvert the host immune response (Ménétrier-Caux
et al. 2009; Mahnke et al. 2007). In our present study, the
observations of poor generation of the maturation marker
CD40 on DCs following H. pylori infection and less IL-17
expression in gastric cancer patients indicated that immature
DCs impaired the DCs’ capacity to induce autologous T-cell
activation. Furthermore, the inhibitory potential of immature
DCs in gastric cancer patients may be an explanation for the
immune escape mechanism of this persistent pathogen during
cancer development.
Regulatory T cells (Treg) and dendritic cells (DC) play an
important role in tumor immunity and immune escape
(Kandulski et al. 2010). Regulatory immune cells, mostly
regulatory Foxp3+CD4+CD25+ T cells (Treg cells), have been
identified as a major regulatory component of the adaptive
immune response and are involved in H. pylori-related in-
flammation and bacterial persistence (Shen et al. 2010). Only
mature/activated DCs stimulate T-cell proliferation. Immature
DCs have tolerogenic properties and can induce nonprolifer-
ative Tregs and suppress proliferation of CD4+ and CD8+
effector T cells. There is growing evidence that expression of
the Treg marker Foxp3mRNA is higher in the gastric tissue of
H pylori-infected individuals, a characteristic that may con-
tribute to immune tolerance (Shen et al. 2010). Extensive
Foxp3+ Treg infiltration and a high Foxp3+/CD8+ ratio are
also associated with poor prognosis in gastric cancer (Shen et
al. 2010). Schuler et al. reported thatMDDC in advanced head
and neck squamous cell carcinoma (HNSCC) patients show a
maturation deficiency ex vivo, and these patients have a higher
frequency of Tregs compared with healthy controls (p00.001)
(Schuler et al. 2011).
Previous reports have stated that T regulatory cells (Tregs)
suppress the inflammatory reaction driven by IL-17, thereby
favoring bacterial persistence (Schuler et al. 2011; Velin et al.
2009). The pro-inflammatory cytokine IL-17 can induce se-
vere inflammation with infiltration of neutrophils and is a key
mediator in the host defense against bacterial organisms
(Kabir 2011; Schuler et al. 2011). In an animal model, treat-
ment with anti-IL-17 antibodies led to a significantly greater
inhibition of inflammation and reduction ofHelicobacter infec-
tion in comparison with control antibodies (Velin et al. 2009).
Our data show increased IL-17 expression in response to
H. pylori in both healthy controls and gastric cancer patients,
but significantly lower IL-17 in gastric cancer patients. We
speculate that H. pylori infection induces immature MDDCs
in gastric cancer patients, which may increase gastric regula-
tory Tcell (Treg) responses. Furthermore, lower IL-17 expres-
sion in gastric cancer patients may be suppressed by Treg
cells; it may drive Th17/Treg balance toward a Treg bias and
lead to an ineffective host immune response to eradicate H.
pylori. Prospective studies of Tregs in gastric cancer patients
infected with H. pylori are necessary to assess these
hypotheses.
The risk for developing cancer rises substantially as a result
of poorly regulated inflammatory responses to pathogenic
bacterial infections. Individuals with a weakened IL-10 medi-
ated inhibitory loop are highly susceptible to the carcinogenic
consequences of elevated inflammation and show more fre-
quent inflammation-associated cancers. Previous studies have
indicated that induction of an H. pylori-specific Th1 response
is a crucial component of protective immunity againstH. pylori
(Eaton et al. 2001; Shi et al. 2010; Takeshima et al. 2009;
Zhang et al. 2008). Individuals carrying genotypes associated
with increased pro-inflammatory cytokine production and/or
decreased anti-inflammatory cytokine IL-10 production report-
edly have increased risk of gastric cancer. The Th2 cytokine
IL-10 can down-regulate the host immune response by modu-
lating the Helicobacter-specific Th1 immune response and
reducing the severity of gastritis induced by H. pylori (Eaton
et al. 2001).
In our present study, stimulation with H. pylori led to
increased IL-10 production by MDDCs. However, IL-10 ex-
pression was significantly lower in MDDCs from gastric can-
cer patients as compared with healthy controls. We speculate
that immature DCs in gastric cancer patients do not produce
sufficient IL-10. Furthermore, the low IL-10 levels were insuf-
ficient to modulate the Helicobacter-specific Th1 immune
response and may cause severe inflammation and hyperres-
ponsiveness in the gastric lumen, leading to gastric diseases.
The mechanism of H. pylori recognition by DCs and the
intracellular signaling pathways that regulate IL-10 expres-
sion are poorly understood. Rad et al. (2007, 2009) have
identified a MyD88-dependent component of the DC acti-
vation program that is induced by surface TLRs recognizing
H pylori. Mean et al. showed that H. pylori induces DC
maturation through TLR binding (Means et al. 2003).
The C-type lectin DC-SIGN, which is a dendritic cell
pathogen-associated molecular pattern (PAMP) receptor, par-
ticipates in the recognition and capture of numerous viral,
bacterial, and fungal pathogens (Geijtenbeek et al. 2004;
Naarding et al. 2006). There are some studies reported the
DC-SIGN receptor on DCs and its effects on cytokine regu-
lation after H. pylori infection (Bergman et al. 2004;
Gringhuis et al. 2009). Our results provide insight into the
mechanisms ofH. pylori recognition by DCs and indicate that
regulation of IL-10 expression is mediated by TLR2, TLR4,
and DC-SIGN receptors on DCs. Due to anti-DC-SIGN,
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TLR2, or TLR4 antibodies treatment alone blocked IL-10
production almost completely, therefore it was hard to observe
the further enhanced effect when any antibody combination
treatment was used. Nevertheless, the process whereby H.
pylori binds to DCs is highly complex, and further study is
needed to determine whether candidate receptors function
alone or in concert with other surface components during this
process.
Whether the MAPK intracellular signaling pathway medi-
ates IL-10 expression in DCs infected with H. pylori is still
unclear. NF-κB, a key coordinator of innate immunity and
inflammation (Karin 2006), regulates the expression of genes
encoding inflammatory cytokines such as IL-10. NF-κB is a
heterodimeric protein which consists of a p50 and a p65
subunit; phosphorylation of p65 enables translocation of the
p50–p65 complex to the nucleus, where it interacts with the
transcriptional coactivators p300 and CBP, which contain his-
tone acetyltransferase domain. Immune subversion by histone
modification correlates with changes in host gene expression
(Li et al. 2007). Our results show that DCs treated with H.
pylori exhibit preferential activation of the p-38 MAPK path-
way as well as differential effects on IL-10 expression associ-
ated with enhanced histone modifications at the IL-10 gene
locus. Adding acetylation and methylation inhibitors ablated
the IL-10 expression induced by H. pylori. These observations
demonstrate thatH. pylori regulates DC function via epigenetic
modulation of IL-10 cytokine expression. Due to the limited
availability of MDDCs from gastric cancer patients, intracellu-
lar events in H. pylori infected dendritic cells (DCs) from
healthy individuals were evaluated in this study.Whether lower
IL-10 production in gastric cancer patients than healthy con-
trols results from the presence of immature DC or impaired
intracellular signaling pathways merits evaluation in further
work.
In conclusion, our study shows that MDDCs from gastric
cancer patients produce significantly lower levels of IL-10,
and show poor maturation and failure to induce a robust Th17
response in response to H. pylori. These data suggest that
defective DC responses to H. pylori in gastric cancer patients
may impair the elimination of H. pylori in early stages and
precipitate the persistent colonization afterwards. The func-
tional alterations of MDDCs may contribute to chronic infec-
tion and cancer development. In the presence of H. pylori,
TLR/DC-SIGN positively regulates MDDC maturation and
IL-10 cytokine production via the p38-MAPK signaling and
histone modification.
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